Hassan to testify in Celebrex suit

Schering-Plough CEO Fred Hassan has been ordered to testify via videotape in a trial over the painkiller Celebrex, which Pfizer acquired in its merger with Pharmacia--the company that was headed up by Hassan when Celebrex was launched. Though Pfizer has settled some Celebrex lawsuits, brought by plaintiffs who said the painkiller caused their heart attacks or strokes, this is the first such suit to reach trial. Report

Suggested Articles

Post-Tesaro buyout, don’t expect GlaxoSmithKline to spring for more commercial-stage oncology products anytime soon.

Already a fast-growing blockbuster, Novo Nordisk's injectable Ozempic won a major heart-helping FDA nod that could bode well for its oral sibling.

Bayer's new Vitrakvi for tumors with NTRK gene fusions is meeting skepticism in England and Germany, where cost watchdogs on Friday rejected it.